50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine

Around 50,000 people, across a number of countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in...